Multi-cancer screening. Multiple ways to pay.
We believe that multi-cancer early detection should be for everyone. We offer a variety of payment options designed to meet your needs.
The cost of the Galleri® test may vary.
Most health insurance plans do not cover the cost of the Galleri test.

Financial Assistance Program
At GRAIL, we believe access to early cancer detection should be accessible for everyone because cancer can impact anyone regardless of background, income, or circumstance. GRAIL created this program to provide financial assistance towards the cost of the Galleri test for eligibile individuals with demonstrated financial need.*
To qualify for financial assistance for the Galleri test, you must:
- Live in the U.S. or Puerto Rico
- Have an annual household income at or below 400% of the Federal Poverty Level (FPL)**
Complete the following fields to see if you may be eligible for financial assistance for the Galleri test:
*GRAIL may change or update its program criteria at any time, without notice. Eligibility is not guaranteed. This calculator provides a preliminary assessment only. GRAIL requires that a patient submits an application with supporting documentation. We encourage you to request financial assistance after you have received a bill and before making any payment. Payments that have already been made cannot be refunded. If you have questions, please contact us.
**More information about the Federal Poverty Level can be found here: U.S. Department of Health and Human Services
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.